Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-08-05FDA Approved: ENHERTU — Supplemental Application (Daiichi Sankyo Inc.)
FDA approved a supplemental application for ENHERTU (fam-trastuzumab deruxtecan-nxki) from Daiichi Sankyo Inc. to update labeling and/or add…
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer [Phase 2]
Phase 2 clinical trial comparing immunotherapy combined with neoadjuvant therapy versus neoadjuvant therapy alone for stage II-III breast ca…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer [Phase 2]
Phase 2 trial update for bevacizumab plus paclitaxel with maintenance endocrine therapy in metastatic breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer [Phase 3]
Phase 3 clinical trial comparing Oraxol to Taxol in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Bicalutamide in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial investigating bicalutamide for metastatic breast cancer has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2022-08-03Clinical Trial Update: Brain Irradiation and Tremelimumab in Metastatic Breast Cancer [NA]
Clinical trial update for brain irradiation and tremelimumab in metastatic breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial [Phase 2]
Phase II trial evaluating the combination of Pyrotinib Maleate, a CDK4/6 inhibitor, and letrozole for stage II-III triple-positive breast ca…
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy [Phase 2, Phase 3]
Clinical trial update investigating magnesium sulfate added to bupivacaine for serratus anterior plane block in modified radical mastectomy;…
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Neoadjuvant Radiation in Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial update investigating neoadjuvant radiation in locally advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating tolerability of combining lapatinib with trastuzumab in adults aged 60 and older with HER2-positive locally advance…
-
FDA approval · 2022-07-27FDA Approved: PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND — Original Application (American Regent, Inc.)
FDA approved paclitaxel protein-bound particles albumin-bound (paclitaxel) from American Regent, Inc. under an Original Application (NDA2118…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients [Phase 1, Phase 2]
Clinical trial update for LUT014 evaluating its use in radiation-induced dermatitis in breast cancer patients across Phase 1 and Phase 2, wi…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 trial update evaluating nab-paclitaxel in older patients with locally advanced or metastatic breast cancer; results have been posted…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer [Phase 2]
Phase 2 umbrella study evaluating molecularly targeted therapies in luminal advanced breast cancer; status not specified in available data.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Dalpiciclib Plus Letrozole and Capecitabine [Phase 2]
Phase 2 trial update of dalpiciclib in combination with letrozole and capecitabine for advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer [NA]
This clinical trial evaluates whether Cu-64-DOTA-Trastuzumab PET imaging can predict response to ado-trastuzumab emtansine in metastatic HER…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification [Phase 2]
A Phase 2 trial evaluating carvedilol to prevent cardiotoxicity from anthracycline and anti-HER2 therapy in women with HER2-positive breast …
-
FDA approval · 2022-07-08FDA Approved: EXEMESTANE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application to bring a generic Exemestane product to market. The sponsor is Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. [Phase 3]
A Phase 3 randomized, double-blind trial evaluating FCN-437c plus letrozole or anastrozole (± goserelin) versus placebo in HR+/HER2- advance…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer [Phase 2]
A Phase 2 trial update for neoadjuvant therapy combining Inituomab, Pyrrolidone, and Nab-paclitaxel in HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. [Phase 3]
Phase III randomized trial evaluating FCN-437c in combination with fulvestrant ± goserelin versus placebo with fulvestrant ± goserelin in HR…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: A Study for the Adjuvant Treatment of Breast Cancer [Phase 4]
Phase 4 clinical trial updating adjuvant treatment for breast cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: A Study for the Neoadjuvant Treatment of Breast Cancer [Phase 4]
A Phase 4 clinical trial update for neoadjuvant treatment of breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing [Phase 2]
Phase 2 trial evaluating adding entinostat to continued aromatase inhibitor therapy in postmenopausal women with ER-positive breast cancer p…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR) [Phase 2]
Phase 2 clinical trial of orteronel as monotherapy in patients with metastatic breast cancer expressing the androgen receptor has completed …